"The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the misuse of such dual-use APIs that are being frequently imported from unregistered sources," said another senior government official.
Once the list of such APIs are prepared, it will be submitted to the Department of Pharmacueticals, he said.
is strictly monitoring the import of such dual-use APIs for the last few months so as to get an idea on what kind of action should be taken, he added.
India imports almost 80 per cent of its API requirement from China.
In India, if a company has to import a dual-use API, it has to give an affidavit to the CDSCO
that a particular API is being imported from a specific registered company and it will be used in making a particular medicine or medicines only.
According to the first senior official quoted above, most of such dual-use APIs are in high demand in the pharma industry as well as special food products industry.